菜单

Panjiva_research_logo

Vaccine, PPE sourcing likely behind U.S. medicine withdrawal from WTO supply chain pact

Coronavirus 501 Health Care 340 U.S. 5146 WTO 113

The U.S. government has filed to withdraw certain medicines from the WTO’s Government Procurement Agreement rules in order to implement “Buy American” health care sourcing during the pandemic. Both the Trump and Biden administration’s have committed to sourcing locally and the move comes as U.S. imports of pharmaceutical categories including drugs needed to treat COVID-19 fell by 8.3% year over year in October. Supplies of PPE and diagnostics climbed by 83.2% and 40.2% respectively, though shipments are below their summer peaks. Imports of vaccines and immunologicals, including those by ...

Copyright © 2021 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.